GE Healthcare has entered an agreement to acquire the assets of OMS, a subsidiary of Orbotech, Yavne, Israel.
OMS manufactures cadmium zinc telluride (CZT) detector technology—a key component of GE’s Alcyone nuclear medicine platform. GE utilizes this technology on the Discovery NM 530c and Discovery NM/CT 570c cardiac SPECT machines.
With Alcyone, views are acquired simultaneously during a fully stationary SPECT acquisition, eliminating equipment movement during the scan and reducing the risk of motion artifacts. CZT detectors directly convert gamma rays into digital signals, eliminating the need for crystals and photomultiplier tubes.
